In patients with type 2 diabetes and metabolic syndrome, HMW adiponectin has been found to be a more effective indicator of insulin resistance associated with type 2 diabetes than total plasma adiponectin levels [8]. Here, ADIPOQ is linked to metabolic syndrome.